Electrification · Power grids · Data centres
See what the market
hasn’t priced in.
Clear, evidence-led analysis of exceptional businesses — built around quality, competitive advantage and the price you pay. Every thesis ends with a decision.
01 / RESEARCH
Latest investment theses
Business quality first.
Valuation always.
Diagnostics · Microbiology · Recurring revenue
bioMérieux
The invisible tollbooth in the fight against infection
Space · AI infrastructure · Governance
SpaceX–Tesla
Industrial vision or private power without counterweights?
Market infrastructure · Clearing · Capital allocation
Euronext
What is the business behind the stock market worth?
View all research 17 earlier reports
EssilorLuxottica
A lifetime holding — at what price?
LVMH
Can it renew desire and create value again?
monday.com
Can AI growth become shareholder cash?
FICO
What is pricing power worth when customers have a choice?
GTT
Exceptional margins. A cyclical earnings stream.
TechnipFMC
The best subsea story is no longer cheap.
Intuit
The financial operating system AI cannot easily replace.
Uber
The ecosystem is becoming the moat.
Hesai
Giving physical AI its eyes.
Schneider Electric
Everyone can see the future. Who will capture the value?
Exosens
Exceptional technology. A price that demands patience.
ASML
China built a machine. It has not yet built a competitor.
Netflix
The winner of streaming faces a new kind of competitor.
Eiffage
The debt is visible. The compounding engine is not.
GE Vernova
The backlog is real. The valuation is the risk.
Novo Nordisk
Is the market pricing a slowdown — or making a mistake?
Copart
A great business that stopped being untouchable
03 / QUARTERLY PORTFOLIO
One Quarter.
Five stocks.
A $10,000 portfolio. Five equally weighted US-listed equities. One quarter to test a disciplined process combining quality, momentum, trend and risk.
The Q4 selection: five disclosed holdings, 20% each. Model entry basis: the regular-session opening price on 1 October 2026. Every result will be reported — positive or negative.
NVIDIA
NVDA
$2,000 starting allocationReported open: $229.98Price source ↗Eaton
ETN
$2,000 starting allocationReported open: $429.63Price source ↗Agilent Technologies
A
$2,000 starting allocationReported open: $172.00Price source ↗ExxonMobil
XOM
$2,000 starting allocationReported open: $161.50Price source ↗Nasdaq Inc.
NDAQ
$2,000 starting allocationReported open: $92.32Price source ↗Opening references above are from Stock Analysis (S&P Global Market Intelligence), checked on 2 October 2026. NVIDIA opening quotes differ between providers; official opening-auction validation remains pending. Q4 performance will be published once the entry references are finalised. This is a model portfolio, not a record of executed trades.
ONE QUARTER · Q4 2026
Quarter performance.
The Q4 return will be measured from the verified opening references on 1 October, including cash dividends and corporate-action adjustments. Entry validation is still pending.
EARLIER EXPERIMENT · 25 JUL — 25 OCT
Previously published scorecard.
This snapshot belongs to the earlier undisclosed experiment. Its quarter return measures this earlier portfolio against its $10,612.52 value at the 30 September close. These figures are separate from the new Q4 selection above.
MEMBERSHIP · 2027
Independent research
worth returning to.
MITUXA is preparing a Free + Premium research service for 2027. Full Premium research will be published in French: one company analysis and one policy or economics analysis every week. A public English summary will keep the central argument open internationally.
French Premium · English public summary · €9.90 monthly or €99 annually